Stephen P. Zano, Ph.D.

Affiliations: 
2013 Chemistry The University of Toledo 
Area:
General Chemistry, Biochemistry
Google:
"Stephen Zano"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Ronald E. Viola grad student 2013 The University of Toledo
 (Therapeutic Approaches for the Treatment of Canavan Disease and Regulation of Bacterial Quorum Sensing Pathway.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Parungao GG, Zhao M, Wang Q, et al. (2017) Complementation of a metK-deficient E. coli strain with heterologous AdoMet synthetase genes. Microbiology (Reading, England)
Zano SP, Pate C, Frank M, et al. (2015) Correction of a genetic deficiency in pantothenate kinase 1 using phosphopantothenate replacement therapy. Molecular Genetics and Metabolism. 116: 281-8
Dansie LE, Reeves S, Miller K, et al. (2014) Physiological roles of the pantothenate kinases. Biochemical Society Transactions. 42: 1033-6
Poddar NK, Zano S, Natarajan R, et al. (2014) Enhanced brain distribution of modified aspartoacylase. Molecular Genetics and Metabolism. 113: 219-24
Zano SP, Pavlovsky AG, Viola RE. (2014) Structure of an unusual S-adenosylmethionine synthetase from Campylobacter jejuni. Acta Crystallographica. Section D, Biological Crystallography. 70: 442-50
Zano SP, Bhansali P, Luniwal A, et al. (2013) Alternative substrates selective for S-adenosylmethionine synthetases from pathogenic bacteria. Archives of Biochemistry and Biophysics. 536: 64-71
Zano S, Wijayasinghe YS, Malik R, et al. (2013) Relationship between enzyme properties and disease progression in Canavan disease. Journal of Inherited Metabolic Disease. 36: 1-6
Zano S, Wijayasinghe YS, Malik R, et al. (2012) Erratum to: Relationship between enzyme properties and disease progression in Canavan disease Journal of Inherited Metabolic Disease. 36: 159-160
Zano S, Malik R, Szucs S, et al. (2011) Modification of aspartoacylase for potential use in enzyme replacement therapy for the treatment of Canavan disease. Molecular Genetics and Metabolism. 102: 176-80
See more...